ProofPilot Announces Strategic Partnership with the Digital Medicine Society to Advance Digital Health in Clinical Trials

NEW YORK, April 29, 2025 /PRNewswire/ — ProofPilot, the industry’s first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and engagement for all study stakeholders, today announced its partnership with the Digital Medicine Society (DiMe), the global non-profit dedicated to driving broad adoption of digital approaches to advance the practice of medicine to enhance public health. Through this collaboration, ProofPilot and DiMe, along with other industry leaders, will drive forward the data-driven development of innovative digital tools for clinical research, prioritizing diverse, accessible, and participant-centered study experiences. The collaboration will work to define and collect physiological signals, behavior traits, and mental health characteristics that will be used to train a tool to prevent opioid use disorder (OUD) relapse.

This collaboration supports DiMe’s mission to advance the safe, effective, and equitable use of digital approaches to redefine healthcare and improve lives. By utilizing ProofPilot’s CoPilot platform, DiMe will enhance study experiences, simplify data collection, and equip sites and participants with streamlined, compliant digital solutions.

“Partnering with DiMe aligns with our mission to improve clinical trials through digital innovation,” said Chris Venezia, CEO of ProofPilot. “Together, we’re bringing digital solutions to the forefront of clinical research, creating streamlined, patient-centered experiences and empowering all participants with advanced tools and support.”

The ProofPilot Clinical Experience platform, deployed across a range of studies – including drug, device, real-world evidence, observational, and behavioral research – will provide DiMe with the technology and engagement tools needed to make clinical trials more efficient and accessible.

Reflecting on the collaboration, Candice Taguibao, Associate Program Director for DiMe, said, “We greatly appreciate the level of engagement and support from the entire ProofPilot team. Their dedication to advancing digital health aligns very well with our mission. We’re excited to work together to implement patient-centered approaches to clinical research and obtain insights to support the development of a digitally derived tool to help prevent relapse and reduce OUD deaths.”

This partnership with DiMe reflects ProofPilot’s commitment to advancing digital health solutions that meet the needs of diverse populations and deliver measurable impact for patient health. The collaboration underscores ProofPilot’s dedication to setting new standards in clinical research by facilitating innovative, patient-friendly digital solutions that address some of the most pressing health challenges today.

About ProofPilot
ProofPilot enhances clinical trials with its Clinical Experience Platform (CXP). The platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience.

About the Digital Medicine Society
DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs.

CONTACT: Hope Mccain | hope.mccain@proofpilot.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/proofpilot-announces-strategic-partnership-with-the-digital-medicine-society-to-advance-digital-health-in-clinical-trials-302440363.html

SOURCE ProofPilot